First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells
byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
Updated on: June 20,2026
First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells
byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
Updated on:June 20,2026
